Haemodynamic and Renal Effects of Dopexamine after Cardiac Surgery in Children

Anaesthesia and Intensive Care

Volumn 24, Issue 4, 1996, Pages 435-439

  Habre, W ^a,b   Beghetti, M ^a,c   Roduit, C ^a,b   Girardin, E ^a,b   Vallotton, M ^a,b   Friedli, B ^a,c   Berner, M ^a,b  

^a Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Canton Hospital of the University of Geneva   (Switzerland)

Author keywords

Heart, surgery: cardiac output, rate, children, dopexamine; Kidney: function

Indexed keywords

DOPAMINE; DOPEXAMINE; DRUG DERIVATIVE; VASODILATOR AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HEART SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY CIRCULATION; MALE; POSTOPERATIVE PERIOD; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; CARDIAC SURGICAL PROCEDURES; CHILD; DOPAMINE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; POSTOPERATIVE PERIOD; RANDOM ALLOCATION; RENAL CIRCULATION; VASODILATOR AGENTS;

EID: 0030203401     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9602400404     Document Type: Article

References (18)

1. Baumann G, Gutting M, Pfafferott C, Ningel K, Klein G. Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure. Eur Heart J 1988; 9:503-512.
2. Coladyn FC, Vandenbogaerde JF. Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure. Am J Cardiol 1988; 62:68C-72C.
3. Leier CV, Binkley PF, Carpenter J, Randolph PH, Unverferth DV. Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol 1988; 62:94-99.
4. Van Der Starre PJA, Rosseel PMJ. Dopexamine hydrochloride after coronary artery bypass grafting. Am J Cardiol 1988; 62:78C-82C.
5. Napoleone P, Cavallotti C, Ricci A, Amenta F. Dopexamine hydrochloride in the human kidney: Localization, receptor binding and effect on 3′-5′-cyclic adenosine monophosphate generation. Nephron 1993; 65:385-391.
6. Olsen NV, Lund J, Jensen PF, et al. Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiology 1993; 79(4):685-694.
7. Zender R, Falbriard A. Analyse colorimétrique des cétohéxoses et de l'inuline par la réaction thiobarbiturique. Clin Chim Acta 1966; 13:246-250.
8. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M. The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945; 24:233-404.
9. Calcagno PL, Rubin MI. Renal extraction of paraaminohippurate in infants and children. J Clin Invest 1963: 42:1632-1639.
10. Jaski EB, Peters C. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride in comparison with dobutamine. Am J Cardiol 1988; 62:63C-67C.
11. Lang RM, Borow KM, Neumann A, et al. Role of the beta 2 adrenoreceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride. Am J Cardiol 1988; 62:46C-52C.
12. Hakim M, Foulds R, Latimer RD, English TAH. Dopexamine hydrochloride a β2 adrenergic and dopaminergic agonist: hemodynamic effects following cardiac surgery. Eur Heart J 1988; 9:853-858.
13. Hunter DN, Gray H, Mudaliar Y, Morgan C, Evans TW. The effects of dopexamine hydrochloride on cardiopulmonary bypass surgery. Int J Cardiol 1989; 23:365-371.
14. Girardin E, Berner M, Rouge JC, Rivest RW, Friedli B, Paunier L. Effect of low dose dopamine on hemodynamic and renal function in children. Pediatr Res 1989; 26:200-203.
15. Ballermann BJ, Zeidel ML, Gunning ME, Brenner BM. Vasoactive peptides and the kidney, The Kidney. Edited by Brenner BM and Rector FC. Philadelphia. WB Saunders Company, 4th edition, 1991; pp 510-583.
16. Marik PE. Low-dose dopamine in critically ill oliguric patients: the influence of the renin-angiotensin system. Heart Lung 1993; 22(2):171-175.
17. Missale C, Lombardi C, De Cotiis R, Memo M, Carruba MO, Spano PF. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview. J Cardiovasc Pharmacol 14 Suppl 1989; 8:S29-39.
18. Fiselier T, Monnens L, van Munster P, Jansen M, Peer P, Lijnen P. The renin-angiotensin-aldosterone system in infancy and childhood in basal conditions and after stimulation. Eur J Pediatr 1984; 143:18-24.